Pipeline Roundup: FDA OKs Watson Asthma Drug as Ariad, Alimera, Hemispherx Move Products Forward

Drug Industry Daily
A A
The FDA has approved Watson’s generic version of children’s asthma drug Pulmicort Respules as several other pharma companies also take steps to advance their pipelines.

To View This Article:

Login

Subscribe To Drug Industry Daily